MRNA

Moderna

D

MRNA

USD

-1.45

(-2.2965%)

مفتوح الان

65,095.00

حجم التداول

-9.925

الربح لكل سهم

-

العائد الربحي

-4.031270

P/E

23,794,114,257.00

حجم السوق

اليوم

-1.9956%

1 اسبوع

-2.766%

1 شهر

-20.052%

6 اشهر

-40.265%

12 اشهر

-40.097%

بداية السنة

-37.803%

كل الوقت

308.989%

التوصيات

الأفكار والتحليلات

أصول ذات صلة

Title:
Moderna

Sector:

Healthcare

Industry:

Biotechnology

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا